← Mechanisms of action
TNFRSF9
SINGLE PROTEINHomo sapiens
Preferred name: Tumor necrosis factor receptor superfamily member 9 ChEMBL ↗
Linked proteins
Drugs acting on this target (67)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| ap601 | Activator | experimental | mAb | TNFRSF9 activator |
| adg206 | Agonist | experimental | mAb | CD137 |
| bi 765179 | Agonist | experimental | Small molecule | TNFRSF9 agonist |
| lbl-024 | Agonist | experimental | Small molecule | TNFRSF9 agonist |
| ro7122290 | Agonist | experimental | mAb | TNFRSF9 agonist |
| twp-101 | Agonist | experimental | mAb | TNFRSF9 agonist |
| urelumab | Agonist | experimental | mAb | TNFRSF9 agonist |
| utomilumab | Agonist | experimental | mAb | TNFRSF9 agonist |
| abl503 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| actr087 | Antagonist | experimental | Cell therapy | TNFRSF9 antagonist |
| atg-101 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| cb307 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| eu101 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| FS-222 | Antagonist | experimental | mAb | CD137 |
| fs222 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| gnc-035 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| gnc-038 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| gnc-039 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| hbm 7008 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| hlx35 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| hot-1030 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| IBI319 | Antagonist | experimental | mAb | CD137 |
| prs-344 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| qlf31907 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| s095012 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| tj033721 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| yh004 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| yh32367 | Antagonist | experimental | mAb | TNFRSF9 antagonist |
| cb307 | Binding agent | experimental | mAb | CD137 |
| cd137l-dc-ebv-vax | Immunity, active | experimental | Vaccine | TNFRSF9 immunity, active |
| 4-1bb selected til | Immunity, passive | experimental | Cell therapy | TNFRSF9 immunity, passive |
| cd137 car-t cells | Immunity, passive | experimental | Cell therapy | TNFRSF9 immunity, passive |
| wu-cart-007 | Immunity, passive | experimental | Cell therapy | TNFRSF9 immunity, passive |
| abl103 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| adg106 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| agen2373 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| alg.apv-527 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| alps12 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| ap203 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| ator-1017 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| bgb-b167 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| BNT314 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| bt7480 | Inhibitor | experimental | Recombinant protein | TNFRSF9 inhibitor |
| ctx-471 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| dsp107 | Inhibitor | experimental | Recombinant protein | TNFRSF9 inhibitor |
| es101 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| fs120 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| ftl008.16 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| gen1042 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| gen1046 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| gen1056 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| inbrx-105 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| lvgn6051 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| mcla-145 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| mdx2003 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| mdx2004 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| mp0310 | Inhibitor | experimental | Recombinant protein | TNFRSF9 inhibitor |
| nbl-028 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| nm21-1480 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| pe0116 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| pm1003 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| pm1032 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| prizloncabtagene autoleucel | Inhibitor | experimental | Cell therapy | TNFRSF9 inhibitor |
| prs-343 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| ro7227166 | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| urelumab | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |
| utomilumab | Inhibitor | experimental | mAb | TNFRSF9 inhibitor |